Ibandronate sodium monohydrate

CAS 138926-19-9

Also known as: Ibandronate sodium (Bonviva)

Indications: This product is used for the treatment of postmenopausal osteoporosis; for the treatment of bone pain caused by osteolytic bone metastasis of malignant tumors; for the treatment of hypercalcemia caused by malignant tumors with or without bone metastasis.

Request a Quote
Category: Pharmaceutical Chemicals APISubcategory: Antineoplastic Drugs APIProduct ID: ibandronate-sodium-monohydrate-138926-19-9
Payment & Shipping Terms Annual Production Capacity
Payment Terms: T/T, WU Annual Production Capacity: 20 MT/year
Min. Order: 1 Gram Packing: according to the customer's requirements
Means of Transport: Ocean, Air, Land Delivery Date: 7 days

Ibandronate sodium monohydrate

CAS 138926-19-9

Indications: This product is used for the treatment of postmenopausal osteoporosis; for the treatment of bone pain caused by osteolytic bone metastasis of malignant tumors; for the treatment of hypercalcemia caused by malignant tumors with or without bone metastasis.

We can customize according to customer's requirement

if you have any question please mail us or call us.

CAS Number 138926-19-9
Molecular Formula C9H24NNaO8P2
Molecular Weight 359.23
Place of Origin Zhejiang,China (Mainland)
Request a quote

Send an inquiry for Ibandronate sodium monohydrate

By sending this inquiry, you acknowledge our Privacy Policy. We use these details only to answer your request.

We usually respond within one business day.

×
MOSINTER chemical operations

Request a Quote

By sending this inquiry, you acknowledge our Privacy Policy. We use these details only to answer your request.

We usually respond within one business day.

MOSINTER GROUP